ARCHIVES

NCI Advisors Approve Plans To Continue Current Research Programs.

This article is from The Cancer Letter archive.

Vol. 34 No. 26 | July 3, 2008

Download PDF Visit The Full Archive

Related Articles

Phase II Trial of BIND-014 Shows Anti-Tumor Activity in Q3W Arm

November 28, 2014

In Brief: Karen Antman And John Glick lead ASCO; ODAC to Meet June 7 On Tamoxifin Trial

May 27, 1994

In Brief: NCI Encourages New Grants In For Cancer Sites In Forthcoming PA, Broder Informs Grantees

January 3, 1992

Komen Foundation Calls For Review Of Action Plan’s Goals

October 24, 1996

Amgen Says It Can Demonstrate Safety of Existing Hg Target.

March 16, 2007

Longer Chemo Regimen Offers Better DFS For Premenopausal Breast Cancer

January 31, 2003